Churg-Strauss syndrome may be induced by leukotriene modifiers in severe asthma [2]

Annals of Allergy, Asthma and Immunology

Volumn 91, Issue 1, 2003, Pages 98-

  Choi, Inseon S ^a   Koh, Youngil I ^a   Joo, Jin Yeong ^a   Lee, Seung Hwan ^a   Bae, Woo Gyun ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PADGEM PROTEIN; PEPTIDOLEUKOTRIENE; PRANLUKAST; PREDNISOLONE; ZAFIRLUKAST;

ADULT; ARTERIAL CARBON DIOXIDE TENSION; ASTHMA; CASE REPORT; CHURG STRAUSS SYNDROME; DIARRHEA; DISEASE EXACERBATION; FEVER; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; LUNG BIOPSY; LUNG EDEMA; MALE; PARESTHESIA; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0042344910     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62071-6     Document Type: Letter

References (5)

1. Weller PF, Plaut M, Taggart V, Trontell A. The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. J Allergy Clin Immunol. 2001;108:175-183.
2. Green RL, Vayonis AG. Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment. Lancet. 1999;353:725-726.
3. Guilpain P, Viallard JF, Lagarde P, et al. Churg-Strauss syndrome in two patients receiving montelukast. Rheumatology. 2002;41:535-539.
4. Solans R, Bosch JA, Selva A, Orriols R, Vilardell M. Montelukast and Churg-Strauss syndrome. Thorax. 2002;57:183-185.
5. Lilly CM, Churg A, Lazarovich M, et al. Asthma therapies and Churg-Strauss syndrome. J Allergy Clin Immunol. 2002;109: S1-S19.